Pharmaceutical Business Review
Manufacturing
Anonymous User | Login

NeoStem Subsidiary Receives Manufacturing Approval In China

Published: 01-Feb-2010

NeoStem has announced that its Suzhou Erye Pharmaceutical subsidiary (Erye) received approval from the State Food and Drug Administration (SFDA) in China, to manufacture solvent crystallization sterile penicillin and freeze dried raw sterile penicillin at their new facility.

The company said that its new facility provides 50% and 100% greater manufacturing capacity, respectively, than its existing facility.

Robin Smith, chairman and CEO of NeoStem, said: "This also is the beginning of Erye's relocation of operations to the new facility, which will continue through 2011, as the new production lines are completed and receive cGMP certification.

"Once Erye has completed its relocation to the new facility, and its new production lines are fully operational, it will have substantially increased its capacity from the current plant with the goal of becoming among the largest antibiotic producers in Eastern China."

NeoStem is engaged in the development of stem cell-based therapies and building of a network of adult stem cell collection centers in the US and China.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Vetter Pharma International

High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...

Turku Region

A Bright Future in a Great Location ...

Thomson Reuters

The World's Leading Source of Life Sciences Intelligent Information ...

Thermo Fisher Scientific

The world leader in serving science ...

Tekni-Plex

Pharmaceutical Packaging Products ...

Solutions4Science

Temperature Mapping and Validation Services ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Your IP at Risk in Collaborations!

Free white paper: Ten steps to protect your R&D investment within partnerships. ...

Why, When and How to Conduct 14C Human Studies

Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...

Why CAPA Still Matters

This free white paper explores the needs and effectiveness of correct CAPA control, how to ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly

Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...

USB HotStart-IT for Real Time PCR

USBĀ® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Related Companies

No items to display

Suppliers Product News

Vetter Dedicates New Facility in Suburban Chicago

The new facility will enable collaboration very early in development process

Pharma Supplier Vetter Shares Pride in Consistent Growth and International Success with Distinguished Visitor Minister zu Guttenberg

Economics and Technology Minister visits global leader's headquarters in southern Germany.

Vetter Packages Success with New Facility

Vetter's new secondary packaging operation allows the company to double its production in half the time.

Finland's Business Environment Ranked Best in the World

The authoritative Economist Intelligence Unit has ranked Finland's business environment as the best in the world for the period 2009-2013.

Finland is the World's Most Prosperous Nation

According to the latest Legatum Prosperity Index, the Finnish economy and society enjoy many of the factors that help drive economic growth and produce happy citizens over the long term. Published for the third time, the Legatum Prosperity Index rates more than 100 nations worldwide according to how well they cultivate empirically-tested drivers of economic and social wellbeing.

Accovion Selects Liquent Insight Publisher

Contract Research Organization Chooses Thomson Reuters Software Solution

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address